Evidence map›Paper›PMID 23695213›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2013

Focal adhesion kinase is required for IGF-I-mediated growth of skeletal muscle cells via a TSC2/mTOR/S6K1-associated pathway.

Hannah Crossland, Abid A Kazi, Charles H Lang, James A Timmons, Philippe Pierre, Daniel J Wilkinson, Kenneth Smith, Nathaniel J Szewczyk, Philip J Atherton

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Impaired mTOR/SREBP1-Mediated Lipogenesis as a Mechanism of Hepatic Glycogen Accumulation in a Carnivorous Fish Model, Largemouth Bass (Micropterus salmoides).FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Molecular mechanisms of exercise contributing to tissue regeneration.Signal transduction and targeted therapy · 2022
    Review
  18. Review
  19. Sarcopenia: Etiology, Nutritional Approaches, and miRNAs.International journal of molecular sciences · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Hannah CrosslandMedical Research Council-Arthritis Research United Kingdom Centre of Excellence for Musculoskeletal Ageing Research, School of Graduate Entry Medicine and Health, University of Nottingham, Royal Derby Hospital, Derby, United Kingdom.
Abid A Kazi
Charles H Lang
James A Timmons
Philippe Pierre
Daniel J Wilkinson
Kenneth Smith
Nathaniel J Szewczyk
Philip J Atherton
Royal Derby Hospital · GBMedical Research Council · GBPennsylvania State University · USCentre d’Immunologie de Marseille-Luminy · FRLoughborough University · GB

Funding

SEPSIS INDUCED INSULIN RESISTANCE IN DIABETESR01GM038032 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI LANG, CHARLES H. · 1992 to 2015
$5.4M
Regulation of Nutrient Sensing and Muscle Wasting by AlcoholR37AA011290 · NIAAA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI LANG, CHARLES H. · 2012 to 2021
$3.4M
Gene Networks Regulating Muscle Protein DegradationR01AR054342 · NIAMS · UNIVERSITY OF NOTTINGHAM · PI SZEWCZYK, NATHANIEL J. · 2007 to 2010
$902k
Medical Research Council G0801271Medical Research Council G1100015Medical Research Council MR/K00414X/1NIAAA NIH HHS R37 AA011290NIAMS NIH HHS R01 AR054342NIAMS NIH HHS R01-AR-054342NIGMS NIH HHS R01 GM038032NIGMS NIH HHS R01-GM-38032
6 · The paper itself

Abstract

Focal adhesion kinase (FAK) is an attachment complex protein associated with the regulation of muscle mass through as-of-yet unclear mechanisms. We tested whether FAK is functionally important for muscle hypertrophy, with the hypothesis that FAK knockdown (FAK-KD) would impede cell growth associated with a trophic stimulus. C₂C₁₂ skeletal muscle cells harboring FAK-targeted (FAK-KD) or scrambled (SCR) shRNA were created using lentiviral transfection techniques. Both FAK-KD and SCR myotubes were incubated for 24 h with IGF-I (10 ng/ml), and additional SCR cells (±IGF-1) were incubated with a FAK kinase inhibitor before assay of cell growth. Muscle protein synthesis (MPS) and putative FAK signaling mechanisms (immunoblotting and coimmunoprecipitation) were assessed. IGF-I-induced increases in myotube width (+41 ± 7% vs. non-IGF-I-treated) and total protein (+44 ± 6%) were, after 24 h, attenuated in FAK-KD cells, whereas MPS was suppressed in FAK-KD vs. SCR after 4 h. These blunted responses were associated with attenuated IGF-I-induced FAK Tyr³⁹⁷ phosphorylation and markedly suppressed phosphorylation of tuberous sclerosis complex 2 (TSC2) and critical downstream mTOR signaling (ribosomal S6 kinase, eIF4F assembly) in FAK shRNA cells (all P < 0.05 vs. IGF-I-treated SCR cells). However, binding of FAK to TSC2 or its phosphatase Shp-2 was not affected by IGF-I or cell phenotype. Finally, FAK-KD-mediated suppression of cell growth was recapitulated by direct inhibition of FAK kinase activity in SCR cells. We conclude that FAK is required for IGF-I-induced muscle hypertrophy, signaling through a TSC2/mTOR/S6K1-dependent pathway via means requiring the kinase activity of FAK but not altered FAK-TSC2 or FAK-Shp-2 binding.

Indexed as

AlgorithmsAnimalsBlotting, WesternCells, CulturedFocal Adhesion Protein-Tyrosine KinasesGenetic VectorsImmunoprecipitationInsulin-Like Growth Factor ILentivirusMiceMuscle Fibers, SkeletalMuscle, SkeletalPhosphorylationRibosomal Protein S6 Kinases, 90-kDaRNA InterferenceRNA, Small InterferingFocal Adhesion Protein-Tyrosine KinasesInsulin-Like Growth Factor ImTOR protein, mouseRibosomal Protein S6 Kinases, 90-kDaRNA, Small InterferingRps6ka1 protein, mouseTOR Serine-Threonine KinasesTsc2 protein, mouseTuberous Sclerosis Complex 2 ProteinTumor Suppressor Proteinsfocal adhesion kinasehypertrophyinsulin-like growth factor-Imammalian target of rapamycinS6 kinase 1skeletal muscletuberous sclerosis complex 2

Identifiers

PMID23695213
PMCPMC3725543
OpenAlexW2146549766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.